CLASS II Drug recall · Reported 11 Dec 2019 · FDA Enforcement Report

fentaNYL 2500 mcg/ (10 mcg/mL) recalled by QuVa Pharma

QuVa Pharma is recalling fentaNYL 2500 mcg/ (10 mcg/mL) in 0.9% Sodium Chloride Bag Preservative Free, Rx, QuVA, distributed nationwide in the US. The recall was initiated on 12 Nov 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: 10029202 Exp. 11/17/2019, 10029753 Exp. 11/17/2019, 10029756 Exp. 11/17/2019, 10029792 Exp. 11/18/2019, 10029793 Exp. 11/18/2019, 10029808 Exp. 11/18/2019, 10029809 Exp. 11/18/2019, 10029810 Exp. 11/18/2019, 10029757 Exp. 11/17/2019, 10029758 Exp. 11/17/2019, 10029809 Exp. 11/18/2019, 10029810 Exp. 11/18/2019, 10029920 Exp. 11/19/2019, 10029897 Exp. 11/20/2019, 10029793 Exp. 11/18/2019, 10029920 Exp. 11/19/2019, 10030394 Exp. 11/25/2019, 10030395 Exp. 11/25/2019, 10030479 Exp. 11/27/2019, 10030480 Exp. 11/27/2019, 10030481 Exp. 11/27/2019, 10030449 Exp. 11/26/2019, 10030450 Exp. 11/26/2019, 10030451 Exp. 11/26/2019, 10030883 Exp. 12/2/2019, 10030885 Exp. 12/2/2019, 10030507 Exp. 11/27/2019, 10030508 Exp. 11/27/2019, 10030936 Exp. 12/3/2019, 10030937 Exp. 12/3/2019, 10030956 Exp. 12/3/2019, 10030903 Exp. 11/30/2019, 10030904 Exp. 11/30/2019, 10030988 Exp. 12/4/2019, 10030938 Exp. 12/3/2019, 10030955 Exp. 12/3/2019, 10030884 Exp. 11/30/2019, 10030902 Exp. 11/30/2019, 10030986 Exp. 12/4/2019, 10030987 Exp. 12/4/2019, 10031009 Exp. 12/4/2019, 10031127 Exp. 12/8/2019, 10031128 Exp. 12/8/2019, 10031150 Exp. 12/8/2019, 10031009 Exp. 12/4/2019, 10030506 Exp. 11/27/2019, 10030448 Exp. 11/26/2019, 10031176 Exp. 12/9/2019, 10031385 Exp. 12/9/2019, 10031127 Exp. 12/8/2019, 10031128 Exp. 12/8/2019, 10031149 Exp. 12/8/2019, 10031234 Exp. 12/10/2019, 10031235 Exp. 12/10/2019, 10031259 Exp. 12/10/2019, 10031261 Exp. 12/10/2019, 10031177 Exp. 12/9/2019, 10031384 Exp. 12/9/2019, 10030426 Exp. 11/26/2019, 10030427 Exp. 11/26/2019, 10031260 Exp. 12/10/2019, 10030957 Exp. 12/3/2019, 10031389 Exp. 12/11/2019, 10030957 Exp. 12/3/2019, 10030904 Exp. 11/30/2019, 10031502 Exp. 12/17/2019, 10031474 Exp. 12/16/2019, 10031503 Exp. 12/17/2019, 10031589 Exp. 12/19/2019, 10031611 Exp. 12/19/2019, 10031565 Exp. 12/18/2019, 10031502 Exp. 12/17/2019, 10031563 Exp. 12/17/2019, 10031693 Exp. 12/22/2019, 10031694 Exp. 12/22/2019, 10031730 Exp. 12/22/2019, 10031588 Exp. 12/19/2019, 10031589 Exp. 12/19/2019, 10031610 Exp. 12/19/2019, 10031564 Exp. 12/18/2019, 10031565 Exp. 12/18/2019, 10031785 Exp. 12/23/2019, 10031693 Exp. 12/22/2019, 10031694 Exp. 12/22/2019, 10031729 Exp. 12/22/2019, 10031640 Exp. 12/20/2019, 10031564 Exp. 12/18/2019, 10031786 Exp. 12/23/2019, 10031810 Exp. 12/23/2019, 10031893 Exp. 12/25/2019, 10031894 Exp. 12/25/2019, 10032247 Exp. 12/30/2019, 10032218 Exp. 12/29/2019, 10031914 Exp. 12/25/2019, 10031915 Exp. 12/25/2019, 10031841 Exp. 12/24/2019, 10031864 Exp. 12/24/2019, 10032217 Exp. 12/29/2019, 10031914 Exp. 12/25/2019, 10031841 Exp. 12/24/2019, 10031842 Exp. 12/24/2019, 10032362 Exp. 1/1/2020, 10032363 Exp. 1/1/2020, 10032387 Exp. 1/1/2020, 10032304 Exp. 12/31/2019, 10032388 Exp. 1/1/2020, 10032554 Exp. 1/6/2020, 10032503 Exp. 1/5/2020, 10032504 Exp. 1/5/2020, 10032554 Exp. 1/6/2020, 10032555 Exp. 1/6/2020, 10032580 Exp. 1/6/2020, 10032581 Exp. 1/6/2020, 10032504 Exp. 1/5/2020, 10032529 Exp. 1/5/2020, 10032530 Exp. 1/5/2020, 10032554 Exp. 1/6/2020, 10032555 Exp. 1/6/2020, 10032581 Exp. 1/6/2020, 10032504 Exp. 1/5/2020, 10032529 Exp. 1/5/2020, 10032530 Exp. 1/5/2020

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0553-2020
FDA event ID
84263
Recalling firm
QuVa Pharma, Sugar Land, TX
Classification
Class II
Status
Terminated
Recall initiated
12 Nov 2019
FDA classified
3 Dec 2019
Reported
11 Dec 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter
Drug class
Pain Medication

Timeline

12 Nov 2019Recall initiated by company
3 Dec 2019Classified by FDA+21 days
11 Dec 2019Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Product as listed by the FDA

fentaNYL 2500 mcg/250 mL (10 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1093-37

Where it was distributed

Nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Which lots are affected?

Lots: 10029202 Exp. 11/17/2019, 10029753 Exp. 11/17/2019, 10029756 Exp. 11/17/2019, 10029792 Exp. 11/18/2019, 10029793 Exp. 11/18/2019, 10029808 Exp. 11/18/2019, 10029809 Exp. 11/18/2019, 10029810 Exp. 11/18/2019, 10029757 Exp. 11/17/2019, 10029758 Exp. 11/17/2019, 10029809 Exp. 11/18/2019, 10029810 Exp. 11/18/2019, 10029920 Exp. 11/19/2019, 10029897 Exp. 11/20/2019, 10029793 Exp. 11/18/2019, 10029920 Exp. 11/19/2019, 10030394 Exp. 11/25/2019, 10030395 Exp. 11/25/2019, 10030479 Exp. 11/27/2019, 10030480 Exp. 11/27/2019, 10030481 Exp. 11/27/2019, 10030449 Exp. 11/26/2019, 10030450 Exp. 11/26/2019, 10030451 Exp. 11/26/2019, 10030883 Exp. 12/2/2019, 10030885 Exp. 12/2/2019, 10030507 Exp. 11/27/2019, 10030508 Exp. 11/27/2019, 10030936 Exp. 12/3/2019, 10030937 Exp. 12/3/2019, 10030956 Exp. 12/3/2019, 10030903 Exp. 11/30/2019, 10030904 Exp. 11/30/2019, 10030988 Exp. 12/4/2019, 10030938 Exp. 12/3/2019, 10030955 Exp. 12/3/2019, 10030884 Exp. 11/30/2019, 10030902 Exp. 11/30/2019, 10030986 Exp. 12/4/2019, 10030987 Exp. 12/4/2019, 10031009 Exp. 12/4/2019, 10031127 Exp. 12/8/2019, 10031128 Exp. 12/8/2019, 10031150 Exp. 12/8/2019, 10031009 Exp. 12/4/2019, 10030506 Exp. 11/27/2019, 10030448 Exp. 11/26/2019, 10031176 Exp. 12/9/2019, 10031385 Exp. 12/9/2019, 10031127 Exp. 12/8/2019, 10031128 Exp. 12/8/2019, 10031149 Exp. 12/8/2019, 10031234 Exp. 12/10/2019, 10031235 Exp. 12/10/2019, 10031259 Exp. 12/10/2019, 10031261 Exp. 12/10/2019, 10031177 Exp. 12/9/2019, 10031384 Exp. 12/9/2019, 10030426 Exp. 11/26/2019, 10030427 Exp. 11/26/2019, 10031260 Exp. 12/10/2019, 10030957 Exp. 12/3/2019, 10031389 Exp. 12/11/2019, 10030957 Exp. 12/3/2019, 10030904 Exp. 11/30/2019, 10031502 Exp. 12/17/2019, 10031474 Exp. 12/16/2019, 10031503 Exp. 12/17/2019, 10031589 Exp. 12/19/2019, 10031611 Exp. 12/19/2019, 10031565 Exp. 12/18/2019, 10031502 Exp. 12/17/2019, 10031563 Exp. 12/17/2019, 10031693 Exp. 12/22/2019, 10031694 Exp. 12/22/2019, 10031730 Exp. 12/22/2019, 10031588 Exp. 12/19/2019, 10031589 Exp. 12/19/2019, 10031610 Exp. 12/19/2019, 10031564 Exp. 12/18/2019, 10031565 Exp. 12/18/2019, 10031785 Exp. 12/23/2019, 10031693 Exp. 12/22/2019, 10031694 Exp. 12/22/2019, 10031729 Exp. 12/22/2019, 10031640 Exp. 12/20/2019, 10031564 Exp. 12/18/2019, 10031786 Exp. 12/23/2019, 10031810 Exp. 12/23/2019, 10031893 Exp. 12/25/2019, 10031894 Exp. 12/25/2019, 10032247 Exp. 12/30/2019, 10032218 Exp. 12/29/2019, 10031914 Exp. 12/25/2019, 10031915 Exp. 12/25/2019, 10031841 Exp. 12/24/2019, 10031864 Exp. 12/24/2019, 10032217 Exp. 12/29/2019, 10031914 Exp. 12/25/2019, 10031841 Exp. 12/24/2019, 10031842 Exp. 12/24/2019, 10032362 Exp. 1/1/2020, 10032363 Exp. 1/1/2020, 10032387 Exp. 1/1/2020, 10032304 Exp. 12/31/2019, 10032388 Exp. 1/1/2020, 10032554 Exp. 1/6/2020, 10032503 Exp. 1/5/2020, 10032504 Exp. 1/5/2020, 10032554 Exp. 1/6/2020, 10032555 Exp. 1/6/2020, 10032580 Exp. 1/6/2020, 10032581 Exp. 1/6/2020, 10032504 Exp. 1/5/2020, 10032529 Exp. 1/5/2020, 10032530 Exp. 1/5/2020, 10032554 Exp. 1/6/2020, 10032555 Exp. 1/6/2020, 10032581 Exp. 1/6/2020, 10032504 Exp. 1/5/2020, 10032529 Exp. 1/5/2020, 10032530 Exp. 1/5/2020

Where was it sold?

Nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

26 other products · FDA event 84263

This product is part of a recall event; the main page for the event is fentaNYL 2000 mcg/ (20 mcg/mL) in 0.9% Sodium Chloride recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIfentaNYL 2000 mcg/ (20 mcg/mL) in 0.9% Sodium Chloride recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 2750 mcg/ (50 mcg/mL) Syringe, Preservative Free recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 2500 mcg/ (50 mcg/mL), Preservative Free, Rx recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 200 mcg/ (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 1250 mcg/ (5 mcg/mL) recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 200 mcg/ (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 800 mcg/ (4 mcg/mL) BUPivacaine HCl recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 550 mcg/ (10 mcg/mL) recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 400 mcg/ (2 mcg/mL) ROPivacaine HCl 0.1% 200 mg recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 200 mcg/ (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 400 mcg/ (2 mcg/mL) 0.1% ROPivacaine HCl 200 mg recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 500 mcg/ (2 mcg/mL) 0.125% BUPivacaine HCl recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 1000 mcg/ (10 mcg/mL) recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 200 mcg/ (2 mcg/mL) BUPivacaine HCl 0.125% 125 mg recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 1000 mcg/ (50 mcg/mL) in Syringe Preservative Free recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 250 mcg/ (50 mcg/mL) Syringe, Preservative Free recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 200 mcg/ (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 100 mcg/ (50 mcg/mL) Preservative Free, Rx recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 1000 mcg/ (10 mcg/mL) recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 1500 mcg/ (50 mcg/mL) in Syringe Preservative Free recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 500 mcg/ (2 mcg/mL) ROPivacaine HCl 0.2% 500 mg recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 400 mcg/ (2 mcg/mL) ROPivacaine HCl 0.2% 400 mg recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 200 mcg/ (2 mcg/mL) 0.125% Bupivacaine HCl 125 mg recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 500 mcg/ (2 mcg/mL) Bupivacaine HCl 0.1% 250 mg recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 1500 mcg/ (50 mcg/mL) PCA Vial Preservative Free recalledQuVa PharmaParticulate MatterNationwide
CLASS IIfentaNYL 500 mcg/ (2 mcg/mL) BUPivacaine HCl recalled by QuVa PharmaQuVa PharmaParticulate MatterNationwide

More recalls from QuVa Pharma

All 38

Other Fentanyl recalls

All 248